Skip to main content

General Dermatology News

Previous studies have inconclusive findings regarding the association of bullous pemphigoid and solid malignancies. A recent study published in The Journal of Dermatology found that patients with bullous pemphigoid do not have an overall increased risk of developing a solid malignancy.
Combination treatment with a home-based handheld narrowband UV-B (NB-UVB) and a topical corticosteroid (TCS) may be a more effective option for treatment of localized vitiligo than TCS alone. The results of the study comparing the two therapies were published in British Journal of Dermatology.
A majority of patients with a symptomatic keloid treated with a 1064-nm Nd:YAG laser exclusively saw a total resolution in pain after treatment. The study results were published in Lasers in Surgery and Medicine.
Findings from a recent study found risankizumab improved both moderate to severe psoriasis symptoms and patients’ quality of life.
Findings from a recent randomized controlled trial showed a broad peroxisome proliferator-activated receptor agonist improved moderate to severe pruritus among patients with primary sclerosing cholangitis and primary biliary cholangitis.
A recent study found an artificial intelligence smartphone app may be a useful clinical tool for helping diagnosis skin diseases in patients with skin of color.
A recent study found rituximab infusions were associated with changes in heart rate and other cardiac adverse effects among patients with pemphigus.
A recent study used surveys to determine which therapies patients found effective for managing hidradenitis suppurativa pain.
Back to Top